Trial Profile
Multicenter phase II trial of neoadjuvant chemotherapy with docetaxel and nedaplatin for oral squamous cell carcinoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Jan 2012
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Nedaplatin (Primary)
- Indications Mouth neoplasm; Squamous cell cancer
- Focus Therapeutic Use
- 13 Jan 2010 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Jun 2009 New trial record.